Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2014 | 1 |
2016 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2024 | 0 |
PubMed (MeSH Keyword) for id: 53377584
6 results
Results by year
Filters applied: . Clear all
Page 1
Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice.
Mol Cell Neurosci. 2021 Jan;110:103583. doi: 10.1016/j.mcn.2020.103583. Epub 2020 Dec 16.
Mol Cell Neurosci. 2021.
PMID: 33338634
Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson's Disease.
Burgaz S, García C, Gómez-Cañas M, Muñoz E, Fernández-Ruiz J.
Burgaz S, et al.
Molecules. 2019 Jul 25;24(15):2702. doi: 10.3390/molecules24152702.
Molecules. 2019.
PMID: 31349553
Free PMC article.
Item in Clipboard
Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
García C, Gómez-Cañas M, Burgaz S, Palomares B, Gómez-Gálvez Y, Palomo-Garo C, Campo S, Ferrer-Hernández J, Pavicic C, Navarrete C, Luz Bellido M, García-Arencibia M, Ruth Pazos M, Muñoz E, Fernández-Ruiz J.
García C, et al.
J Neuroinflammation. 2018 Jan 16;15(1):19. doi: 10.1186/s12974-018-1060-5.
J Neuroinflammation. 2018.
PMID: 29338785
Free PMC article.
Item in Clipboard
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.
Díaz-Alonso J, Paraíso-Luna J, Navarrete C, Del Río C, Cantarero I, Palomares B, Aguareles J, Fernández-Ruiz J, Bellido ML, Pollastro F, Appendino G, Calzado MA, Galve-Roperh I, Muñoz E.
Díaz-Alonso J, et al.
Sci Rep. 2016 Jul 19;6:29789. doi: 10.1038/srep29789.
Sci Rep. 2016.
PMID: 27430371
Free PMC article.
Item in Clipboard
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.
Carrillo-Salinas FJ, Navarrete C, Mecha M, Feliú A, Collado JA, Cantarero I, Bellido ML, Muñoz E, Guaza C.
Carrillo-Salinas FJ, et al.
PLoS One. 2014 Apr 11;9(4):e94733. doi: 10.1371/journal.pone.0094733. eCollection 2014.
PLoS One. 2014.
PMID: 24727978
Free PMC article.
Item in Clipboard
A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis.
Granja AG, Carrillo-Salinas F, Pagani A, Gómez-Cañas M, Negri R, Navarrete C, Mecha M, Mestre L, Fiebich BL, Cantarero I, Calzado MA, Bellido ML, Fernandez-Ruiz J, Appendino G, Guaza C, Muñoz E.
Granja AG, et al.
J Neuroimmune Pharmacol. 2012 Dec;7(4):1002-16. doi: 10.1007/s11481-012-9399-3. Epub 2012 Sep 14.
J Neuroimmune Pharmacol. 2012.
PMID: 22971837
Item in Clipboard
Cite
Cite